148 related articles for article (PubMed ID: 28278563)
1. Development assessment of HIV exposed children aged 6-18 months: a cohort study from North India.
Rajan R; Seth A; Mukherjee SB; Chandra J
AIDS Care; 2017 Nov; 29(11):1404-1409. PubMed ID: 28278563
[TBL] [Abstract][Full Text] [Related]
2. The neurodevelopment of HIV-infected infants on HAART compared to HIV-exposed but uninfected infants.
Whitehead N; Potterton J; Coovadia A
AIDS Care; 2014 Apr; 26(4):497-504. PubMed ID: 24125015
[TBL] [Abstract][Full Text] [Related]
3. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
[TBL] [Abstract][Full Text] [Related]
4. Differences in Growth of HIV-exposed Uninfected Infants in Ethiopia According to Timing of In-utero Antiretroviral Therapy Exposure.
Ejigu Y; Magnus JH; Sundby J; Magnus MC
Pediatr Infect Dis J; 2020 Aug; 39(8):730-736. PubMed ID: 32516280
[TBL] [Abstract][Full Text] [Related]
5. In-utero exposure to antiretrovirals and neurodevelopment among HIV-exposed-uninfected children in Botswana.
Chaudhury S; Mayondi GK; Williams PL; Leidner J; Shapiro R; Diseko M; Ajibola G; Holding P; Tepper V; Makhema J; Petlo C; Seage GR; Lockman S; Kammerer B
AIDS; 2018 Jun; 32(9):1173-1183. PubMed ID: 29547434
[TBL] [Abstract][Full Text] [Related]
6. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
[TBL] [Abstract][Full Text] [Related]
7. Neurodevelopmental and behavioural outcomes of HIV-exposed uninfected and HIV-unexposed children at 2-3 years of age in Cape Town, South Africa.
Springer PE; Slogrove AL; Kidd M; Kalk E; Bettinger JA; Esser MM; Cotton MF; Zunza M; Molteno CD; Kruger M
AIDS Care; 2020 Apr; 32(4):411-419. PubMed ID: 31280587
[TBL] [Abstract][Full Text] [Related]
8. The impact of health programmes to prevent vertical transmission of HIV. Advances, emerging health challenges and research priorities for children exposed to or living with HIV: Perspectives from South Africa.
Goga A; Slogrove A; Wedderburn CJ; Feucht U; Wessels J; Ramokolo V; Bhana A; Du Plessis N; Green RJ; Pillay Y; Sherman G
S Afr Med J; 2019 Dec; 109(11b):77-82. PubMed ID: 32252873
[TBL] [Abstract][Full Text] [Related]
9. Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months.
Chaudhury S; Williams PL; Mayondi GK; Leidner J; Holding P; Tepper V; Nichols S; Magetse J; Sakoi M; Moabi K; Makhema J; Mdluli C; Jibril H; Seage GR; Kammerer B; Lockman S
Pediatrics; 2017 Oct; 140(4):. PubMed ID: 28912368
[TBL] [Abstract][Full Text] [Related]
10. Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV.
Kerr SJ; Puthanakit T; Vibol U; Aurpibul L; Vonthanak S; Kosalaraksa P; Kanjanavanit S; Hansudewechakul R; Wongsawat J; Luesomboon W; Ratanadilok K; Prasitsuebsai W; Pruksakaew K; van der Lugt J; Paul R; Ananworanich J; Valcour V;
AIDS Care; 2014; 26(11):1327-35. PubMed ID: 24878112
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal development of cognitive, visuomotor and adaptive behavior skills in HIV uninfected children, aged 3-5 years of age, exposed pre- and perinatally to anti-retroviral medications.
Smith ML; Puka K; Sehra R; Read SE; Bitnun A
AIDS Care; 2017 Oct; 29(10):1302-1308. PubMed ID: 28482682
[TBL] [Abstract][Full Text] [Related]
12. In utero antiretroviral exposure and sociodemographic characteristics on neurodevelopment of HIV-exposed uninfected children versus HIV-unexposed uninfected healthy children in Malawi.
Zhang X; Wang L; Han J; Xie L; Wu N; Nyirenda R; Shumba K; Simwanza W; Kulyk O; Chilapondwa V; Li X
Int J Gynaecol Obstet; 2021 Jun; 153(3):424-437. PubMed ID: 33270235
[TBL] [Abstract][Full Text] [Related]
13. Five year neurodevelopment outcomes of perinatally HIV-infected children on early limited or deferred continuous antiretroviral therapy.
Laughton B; Cornell M; Kidd M; Springer PE; Dobbels EFM; Rensburg AJV; Otwombe K; Babiker A; Gibb DM; Violari A; Kruger M; Cotton MF
J Int AIDS Soc; 2018 May; 21(5):e25106. PubMed ID: 29722482
[TBL] [Abstract][Full Text] [Related]
14. A description of early neurodevelopment in a cohort of HIV-exposed uninfected children.
Strehlau R; van Aswegen T; Burke M; Kuhn L; Potterton J
AIDS Care; 2020 Nov; 32(11):1421-1428. PubMed ID: 32122174
[No Abstract] [Full Text] [Related]
15. In Utero Efavirenz Exposure and Neurodevelopmental Outcomes in HIV-exposed Uninfected Children in Botswana.
Cassidy AR; Williams PL; Leidner J; Mayondi G; Ajibola G; Makhema J; Holding PA; Powis KM; Batlang O; Petlo C; Shapiro R; Kammerer B; Lockman S
Pediatr Infect Dis J; 2019 Aug; 38(8):828-834. PubMed ID: 30985518
[TBL] [Abstract][Full Text] [Related]
16. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
[TBL] [Abstract][Full Text] [Related]
17. In Utero Exposure to Antiretroviral Drugs: Effect on Birth Weight and Growth Among HIV-exposed Uninfected Children in Brazil.
Hofer CB; Keiser O; Zwahlen M; Lustosa CS; Frota AC; de Oliveira RH; Abreu TF; Carvalho AW; Araujo LE; Egger M
Pediatr Infect Dis J; 2016 Jan; 35(1):71-7. PubMed ID: 26741583
[TBL] [Abstract][Full Text] [Related]
18. Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers.
Lipshultz SE; Williams PL; Zeldow B; Wilkinson JD; Rich KC; van Dyke RB; Seage GR; Dooley LB; Kaltman JR; Siberry GK; Mofenson LM; Shearer WT; Colan SD;
AIDS; 2015 Jan; 29(1):91-100. PubMed ID: 25562493
[TBL] [Abstract][Full Text] [Related]
19. Neurodevelopmental outcomes and in-utero antiretroviral exposure in HIV-exposed uninfected children.
Piske M; Budd MA; Qiu AQ; Maan EJ; Sauvé LJ; Forbes JC; Alimenti A; Janssen P; Côté HCF;
AIDS; 2018 Nov; 32(17):2583-2592. PubMed ID: 30134292
[TBL] [Abstract][Full Text] [Related]
20. Growth of HIV-exposed uninfected, compared with HIV-unexposed, Zambian children: a longitudinal analysis from infancy to school age.
Rosala-Hallas A; Bartlett JW; Filteau S
BMC Pediatr; 2017 Mar; 17(1):80. PubMed ID: 28302082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
